Evidence map›Paper›PMID 38746679›Full record

ArticleFrontiers in oncology2024

A hybrid deep learning scheme for MRI-based preliminary multiclassification diagnosis of primary brain tumors.

Zhichao Wang, Chuchu He, Yan Hu, Haifeng Luo, Chao Li, Xiandong Wu, Yang Zhang, Jingjing Li, Jun Cai

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Advancements in the application of MRI radiomics in meningioma.Radiation oncology (London, England) · 2025
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhichao Wang *Department of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Chuchu He *Department of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Yan HuDepartment of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Haifeng LuoDepartment of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Chao LiDepartment of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Xiandong WuDepartment of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Yang ZhangDepartment of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Jingjing LiDepartment of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Jun CaiDepartment of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The diagnosis and treatment of brain tumors have greatly benefited from extensive research in traditional radiomics, leading to improved efficiency for clinicians. With the rapid development of cutting-edge technologies, especially deep learning, further improvements in accuracy and automation are expected. In this study, we explored a hybrid deep learning scheme that integrates several advanced techniques to achieve reliable diagnosis of primary brain tumors with enhanced classification performance and interpretability. Methods: This study retrospectively included 230 patients with primary brain tumors, including 97 meningiomas, 66 gliomas and 67 pituitary tumors, from the First Affiliated Hospital of Yangtze University. The effectiveness of the proposed scheme was validated by the included data and a commonly used data. Based on super-resolution reconstruction and dynamic learning rate annealing strategies, we compared the classification results of several deep learning models. The multi-classification performance was further improved by combining feature transfer and machine learning. Classification performance metrics included accuracy (ACC), area under the curve (AUC), sensitivity (SEN), and specificity (SPE). Results: In the deep learning tests conducted on two datasets, the DenseNet121 model achieved the highest classification performance, with five-test accuracies of 0.989 ± 0.006 and 0.967 ± 0.013, and AUCs of 0.999 ± 0.001 and 0.994 ± 0.005, respectively. In the hybrid deep learning tests, LightGBM, a promising classifier, achieved accuracies of 0.989 and 0.984, which were improved from the original deep learning scheme of 0.987 and 0.965. Sensitivities for both datasets were 0.985, specificities were 0.988 and 0.984, respectively, and relatively desirable receiver operating characteristic (ROC) curves were obtained. In addition, model visualization studies further verified the reliability and interpretability of the results. Conclusions: These results illustrated that deep learning models combining several advanced technologies can reliably improve the performance, automation, and interpretability of primary brain tumor diagnosis, which is crucial for further brain tumor diagnostic research and individualized treatment.

Indexed as

brain tumor classificationdeep learningmodel interpretabilityMRI imagestransfer learning

Identifiers

PMID38746679
PMCPMC11091367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.